Related references
Note: Only part of the references are listed.European Medicines Agency workshop on biosimilar monoclonal antibodies
Janice M. Reichert et al.
mAbs (2010)
Production of monoclonal antibodies by glycoengineered Pichia pastoris
Thomas I. Potgieter et al.
JOURNAL OF BIOTECHNOLOGY (2009)
Merck joins the biotech game
Victor Bethencourt
NATURE BIOTECHNOLOGY (2009)
A European perspective on immunogenicity evaluation
Christian K. Schneider et al.
NATURE BIOTECHNOLOGY (2009)
Genome sequence of the recombinant protein production host Pichia pastoris
Kristof De Schutter et al.
NATURE BIOTECHNOLOGY (2009)
Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology
Pieter P. Jacobs et al.
NATURE PROTOCOLS (2009)
Gearing up for follow-on biologics
Bethan Hughes
NATURE REVIEWS DRUG DISCOVERY (2009)
Glycosylation as a strategy to improve antibody-based therapeutics
Roy Jefferis
NATURE REVIEWS DRUG DISCOVERY (2009)
Simple high-cell density fed-batch technique for high-level recombinant protein production with Pichia pastoris: Application to intracellular production of Hepatitis B surface antigen
Chandrasekhar Gurramkonda et al.
MICROBIAL CELL FACTORIES (2009)
Microbial factories for recombinant pharmaceuticals
Neus Ferrer-Miralles et al.
MICROBIAL CELL FACTORIES (2009)
The N-Linked sugar chains of human immunoglobulin G: Their unique pattern, and their functional roles
Akira Kobata
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Synthesis and characterization of a functional intact IgG in a prokaryotic cell-free expression system
Stephan Frey et al.
BIOLOGICAL CHEMISTRY (2008)
Characterization of a complex glycoprotein whose variable metabolic clearance in humans is dependent on terminal N-acetylglucosamine content
Rodney Keck et al.
BIOLOGICALS (2008)
Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice
Thomas A. Millward et al.
BIOLOGICALS (2008)
Optimization of chemically defined medium for recombinant Pichia pastoris for biomass production
A. Ghosalkar et al.
BIORESOURCE TECHNOLOGY (2008)
Pichia power: India's biotech industry puts unconventional yeast to work
Chandra Shekhar
CHEMISTRY & BIOLOGY (2008)
Editorial: Therapeutic Antibodies and Derivatives: From the Bench to the Clinic
A. Beck et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Development and Production of Commercial Therapeutic Monoclonal Antibodies in Mammalian Cell Expression Systems: An Overview of the Current Upstream Technologies
Michel Chartrain et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Monoclonal Antibodies as Innovative Therapeutics
Janice M. Reichert
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins
Alain Beck et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery
Andreas Lehmann
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris:: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response
Byung-Kwon Choi et al.
GLYCOCONJUGATE JOURNAL (2008)
The way forward, enhanced characterization of therapeutic antibody glycosylation: Comparison of three level mass spectrometry-based strategies
Elsa Wagner-Rousset et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Toward biosimilar monoclonal antibodies
Christian K. Schneider et al.
NATURE BIOTECHNOLOGY (2008)
Use of high-performance anion exchange chromatography with pulsed amperometric detection for O-glycan determination in yeast
Terrance A. Stadheim et al.
NATURE PROTOCOLS (2008)
Economic issues with follow-on protein products
Michael Lanthier et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose
Christine H. Chung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG fc
Robert M. Anthony et al.
SCIENCE (2008)
Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function
Quin Zhou et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Influence of specific growth rate on specific productivity and glycosylation of a recombinant avidin produced by a Pichia pastoris Mut+ strain
Jonas Schenk et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
N-glycan modification in Aspergillus species
Elke Kainz et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2008)
Production of humanized glycoproteins in bacteria and yeasts
Yasunori Chiba et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2007)
Protein N-glycosylation in the baculovirus-insect cell system
Xianzong Shi et al.
CURRENT DRUG TARGETS (2007)
Glycosylation engineering in yeast: the advent of fully humanized yeast
Stephen R. Hamilton et al.
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Moss bioreactors producing improved biopharmaceuticals
Eva L. Decker et al.
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Peptides as tools and drugs for immunotherapies
Alain Beck et al.
JOURNAL OF PEPTIDE SCIENCE (2007)
From planta to pharma with glycosylation in the toolbox
Claude Saint-Jore-Dupas et al.
TRENDS IN BIOTECHNOLOGY (2007)
Differences in the glycosylation profile of a monoclonal antibody produced by hybridomas cultured in serum-supplemented, serum-free or chemically defined media
J. Antonio Serrato et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2007)
Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1
Shigeki Matsumiya et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion
Jun Qian et al.
ANALYTICAL BIOCHEMISTRY (2007)
Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys
Andrew J. S. Jones et al.
GLYCOBIOLOGY (2007)
Sialylated therapeutic IgG:: a sweet remedy for inflammatory diseases?
Jordan D. Dimitrov et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Glycosylation of therapeutic proteins in different production systems
Rolf G. Werner et al.
ACTA PAEDIATRICA (2007)
Comparison of the methods for profiling glycoprotein glycans - HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study
Yoshinao Wada et al.
GLYCOBIOLOGY (2007)
A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients
Eiji Suzuki et al.
CLINICAL CANCER RESEARCH (2007)
Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III
Gerard J. A. Rouwendal et al.
GLYCOBIOLOGY (2007)
Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality
Bernard J. Scallon et al.
MOLECULAR IMMUNOLOGY (2007)
The impact of glycosylation on the biological function and structure of human immunoglobulins
James N. Arnold et al.
ANNUAL REVIEW OF IMMUNOLOGY (2007)
Compensation of endogenous IgG mediated inhibition of antibody-dependent cellular cytotoxicity by glyco-engineering of therapeutic antibodies
Andreas Nechansky et al.
MOLECULAR IMMUNOLOGY (2007)
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types
Yutaka Kanda et al.
GLYCOBIOLOGY (2007)
Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor
Kevin M. Cox et al.
NATURE BIOTECHNOLOGY (2006)
Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies
Mitsuo Satoh et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
Post-translational modifications in the context of therapeutic proteins
Gary Walsh et al.
NATURE BIOTECHNOLOGY (2006)
Analytical strategies to investigate plant N-glycan profiles in the context of plant-made pharmaceuticals
Muriel Bardor et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
Humanization of yeast to produce complex terminally sialylated glycoproteins
Stephen R. Hamilton et al.
SCIENCE (2006)
Antibody production
John R. Birch et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
Yoshikatsu Kaneko et al.
SCIENCE (2006)
Challenges in therapeutic glycoprotein production
Natarajan Sethuraman et al.
CURRENT OPINION IN BIOTECHNOLOGY (2006)
Genetic defects in the human glycome (vol 7, pg 537, 2006)
Hudson H. Freeze
NATURE REVIEWS GENETICS (2006)
Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC
Yutaka Kanda et al.
BIOTECHNOLOGY AND BIOENGINEERING (2006)
Genetic defects in the human glycome
Hudson H. Freeze
NATURE REVIEWS GENETICS (2006)
Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin g on antibody-dependent cellular cytotoxicity through its high binding to FcγRIIIa
S Iida et al.
CLINICAL CANCER RESEARCH (2006)
Modulation of therapeutic antibody effector functions by glycosylation engineering:: Influence of Golgi enzyme localization domain and co-expression of heterologous β1,4-N-acetylglucosaminyltransferase III and Golgi α-mannosidase II
C Ferrara et al.
BIOTECHNOLOGY AND BIOENGINEERING (2006)
Summary of recombinant human serum albumin development
K Kobayashi
BIOLOGICALS (2006)
Selection of a human anti-RhD monoclonal antibody for therapeutic use:: Impact of IgG glycosylation on activating and inhibitory FcγR functions
S Sibéril et al.
CLINICAL IMMUNOLOGY (2006)
Optimization of humanized IgGs in glycoengineered Pichia pastoris
HJ Li et al.
NATURE BIOTECHNOLOGY (2006)
An engineered human IgG1 antibody with longer serum half-life
PR Hinton et al.
JOURNAL OF IMMUNOLOGY (2006)
Glycosylation of recombinant antibody therapeutics
R Jefferis
BIOTECHNOLOGY PROGRESS (2005)
Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro
J Hodoniczky et al.
BIOTECHNOLOGY PROGRESS (2005)
Selection, design, and engineering of therapeutic antibodies
LG Presta
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Production of human monoclonal antibody in eggs of chimeric chickens
L Zhu et al.
NATURE BIOTECHNOLOGY (2005)
Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals
M Butler
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2005)
Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NSO cells
A Beck et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Cloning and disruption of the Pichia pastoris ARG1, ARG2, ARG3, HIS1, HIS2, HIS5, HIS6 genes and their use as auxotrophic markers
JH Nett et al.
YEAST (2005)
The humanization of N-glycosylation pathways in yeast
S Wildt et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris:: production of complex humanized glycoproteins with terminal galactose
P Bobrowicz et al.
GLYCOBIOLOGY (2004)
Controlled glycosylation of therapeutic antibodies in plants
Y Tekoah et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Methanol induction optimization for scFv antibody fragment production in Pichia pastoris
AE Cunha et al.
BIOTECHNOLOGY AND BIOENGINEERING (2004)
Glycomics: A pathway to a class of new and improved therapeutics
Z Shriver et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Dissolved-oxygen-stat controlling two variables for methanol induction of rGuamerin in Pichia pastoris and its application to repeated fed-batch
HK Lim et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2003)
Analysis and control of proteolysis of a fusion protein in Pichia pastoris fed-batch processes
M Jahic et al.
JOURNAL OF BIOTECHNOLOGY (2003)
High-level expression of recombinant IgG in the human cell line PER.C6
D Jones et al.
BIOTECHNOLOGY PROGRESS (2003)
Cloning and disruption of the PpURA5 gene and construction of a set of integration vectors for the stable genetic modification of Pichia pastoris
JH Nett et al.
YEAST (2003)
Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris
GPL Cereghino et al.
CURRENT OPINION IN BIOTECHNOLOGY (2002)
Expression of full-length immunoglobulins in Escherichia coli:: rapid and efficient production of aglycosylated antibodies
LC Simmons et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris
C Marty et al.
PROTEIN EXPRESSION AND PURIFICATION (2001)
Application of liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry to the analysis of the site-specific carbohydrate heterogeneity in erythropoietin
N Kawasaki et al.
ANALYTICAL BIOCHEMISTRY (2000)
Share Paper
